News & AnalysisCDR-Life scores $76m Series ACDR-Life Inc., a biotechnology company, has secured $76 million in Series A financing.ByIris Dorbian13 April 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs